Details of the Drug Formulations

General Information of Drug (ID: DMI2QPE)

Drug Name

Didanosine Drug Info

Synonyms

didanosine; 69655-05-6; DIDEOXYINOSINE; Videx; Videx EC; Inosine, 2',3'-dideoxy-; ddIno; Didanosina; Didanosinum; DDI; BMY-40900; UNII-K3GDH6OH08; K3GDH6OH08; Didanosinum [INN-Latin]; Didanosina [INN-Spanish]; CHEBI:490877; 9-(2,3-Dideoxy-beta-D-ribofuranosyl)-6-oxopurine; NSC 612049; 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one; 9-[(2R,5R)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL]-1,9-DIHYDRO-6H-PURIN-6-ONE; NCGC00159514-02; NCGC00090691-03; DRG-0016; BMY 40900; DSSTox_CID_2927

Indication

Disease Entry	ICD 11	Status	REF
Human immunodeficiency virus infection	1C62	Approved	[1]

Therapeutic Class

Anti-HIV Agents

Cross-matching ID

PubChem CID: 135398739
ChEBI ID: CHEBI:490877
CAS Number: 69655-05-6
TTD ID: D06FDR
VARIDT ID: DR01175
ACDINA ID: D00195

Full List of Drug Formulations Containing This Drug

Didanosine 200 mg capsule

Company	Formulation ID	FDA Description
Teva Pharmaceuticals	F05861	D&c yellow no. 10; Fd&c red no. 40; D&c red no. 33; Fd&c blue no. 1; Fd&c blue no. 2; Fd&c yellow no. 6; Indigotindisulfonate sodium; Ferrosoferric oxide; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Triacetin; Triethyl citrate; Croscarmellose sodium; Silicon dioxide; Gelatin, unspecified; Hydroxypropyl cellulose (1200000 mw); Hypromellose 2910 (3 mpa.s); Hypromellose 2910 (50 mpa.s); Hypromellose 2910 (6 mpa.s); Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Microcrystalline cellulose; Polydextrose; Polyethylene glycol 8000; Shellac
Mylan Pharamceuticals	F05860	Sodium lauryl sulfate; Diethyl phthalate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Talc; Titanium dioxide; Trisodium citrate dihydrate; Carboxymethylcellulose sodium; Silicon dioxide; Gelatin; Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Sodium starch glycolate type a potato
Aurobindo Pharma	F05862	Sodium lauryl sulfate; Diethyl phthalate; Ferrosoferric oxide; Talc; Titanium dioxide; Carboxymethylcellulose sodium; Silicon dioxide; Gelatin; Hypromellose 2910 (3 mpa.s); Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Shellac; Sodium starch glycolate type a potato
Bristol-Myers Squibb Company	F05859	Diethyl phthalate; Sodium hydroxide; Talc; Titanium dioxide; Carboxymethylcellulose sodium; Gelatin; Methacrylic acid - methyl methacrylate copolymer (1:2); Sodium starch glycolate type a potato
------------------------------------------------------------------------------------

Didanosine 400 mg capsule

Company	Formulation ID	FDA Description
Teva Pharmaceuticals	F05872	D&c yellow no. 10; Fd&c red no. 40; D&c red no. 33; Fd&c blue no. 1; Fd&c blue no. 2; Fd&c yellow no. 6; Indigotindisulfonate sodium; Ferrosoferric oxide; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Triacetin; Triethyl citrate; Croscarmellose sodium; Silicon dioxide; Gelatin, unspecified; Hydroxypropyl cellulose (1200000 mw); Hypromellose 2910 (3 mpa.s); Hypromellose 2910 (50 mpa.s); Hypromellose 2910 (6 mpa.s); Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Microcrystalline cellulose; Polydextrose; Polyethylene glycol 8000; Shellac
State of Florida DOH Central Pharmacy	F05870	D&c yellow no. 10; Fd&c red no. 40; D&c red no. 33; Fd&c blue no. 1; Fd&c blue no. 2; Fd&c yellow no. 6; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Triacetin; Triethyl citrate; Croscarmellose sodium; Hypromellose; Silicon dioxide; Cellulose, microcrystalline; Ferric oxide; Gelatin; Hydroxypropyl cellulose; Methacrylic acid; Polydextrose; Polyethylene glycol; Shellac
Mylan Pharamceuticals	F05871	Sodium lauryl sulfate; Diethyl phthalate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Talc; Titanium dioxide; Trisodium citrate dihydrate; Carboxymethylcellulose sodium; Silicon dioxide; Gelatin; Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Sodium starch glycolate type a potato
Aurobindo Pharma	F05873	Sodium lauryl sulfate; Diethyl phthalate; Ferrosoferric oxide; Talc; Titanium dioxide; Carboxymethylcellulose sodium; Silicon dioxide; Gelatin; Hypromellose 2910 (3 mpa.s); Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Shellac; Sodium starch glycolate type a potato
Bristol-Myers Squibb Company	F05869	Diethyl phthalate; Sodium hydroxide; Talc; Titanium dioxide; Carboxymethylcellulose sodium; Gelatin; Methacrylic acid - methyl methacrylate copolymer (1:2); Sodium starch glycolate type a potato
------------------------------------------------------------------------------------

Didanosine 250 mg capsule

Company	Formulation ID	FDA Description
Teva Pharmaceuticals	F05867	D&c red no. 28; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Ferrosoferric oxide; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Triacetin; Triethyl citrate; Croscarmellose sodium; Silicon dioxide; Gelatin, unspecified; Hydroxypropyl cellulose (1200000 mw); Hypromellose 2910 (3 mpa.s); Hypromellose 2910 (50 mpa.s); Hypromellose 2910 (6 mpa.s); Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Microcrystalline cellulose; Polydextrose; Polyethylene glycol 8000; Shellac
State of Florida DOH Central Pharmacy	F05864	D&c red no. 28; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Triacetin; Triethyl citrate; Croscarmellose sodium; Hypromellose; Silicon dioxide; Cellulose, microcrystalline; Ferric oxide; Gelatin; Hydroxypropyl cellulose; Methacrylic acid; Polydextrose; Polyethylene glycol; Shellac
Physicians Total Care	F05866	D&c red no. 28; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Ferrosoferric oxide; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Triacetin; Triethyl citrate; Croscarmellose sodium; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Gelatin; Hydroxypropyl cellulose; Hypromelloses; Methacrylic acid; Polydextrose; Polyethylene glycol; Shellac
Mylan Pharamceuticals	F05865	Sodium lauryl sulfate; Diethyl phthalate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Talc; Titanium dioxide; Trisodium citrate dihydrate; Carboxymethylcellulose sodium; Silicon dioxide; Gelatin; Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Sodium starch glycolate type a potato
Aurobindo Pharma	F05868	Sodium lauryl sulfate; Diethyl phthalate; Ferrosoferric oxide; Talc; Titanium dioxide; Carboxymethylcellulose sodium; Silicon dioxide; Gelatin; Hypromellose 2910 (3 mpa.s); Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Shellac; Sodium starch glycolate type a potato
Bristol-Myers Squibb Company	F05863	Diethyl phthalate; Sodium hydroxide; Talc; Titanium dioxide; Carboxymethylcellulose sodium; Gelatin; Methacrylic acid - methyl methacrylate copolymer (1:2); Sodium starch glycolate type a potato
------------------------------------------------------------------------------------


⏷ Show the Full List of 6 Formulation(s)

Didanosine 125 mg capsule

Company	Formulation ID	FDA Description
Mylan Pharamceuticals	F05857	Sodium lauryl sulfate; Diethyl phthalate; Ammonia; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Talc; Titanium dioxide; Trisodium citrate dihydrate; Carboxymethylcellulose sodium; Silicon dioxide; Gelatin; Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Sodium starch glycolate type a potato
Aurobindo Pharma	F05858	Sodium lauryl sulfate; Diethyl phthalate; Ferrosoferric oxide; Talc; Titanium dioxide; Carboxymethylcellulose sodium; Silicon dioxide; Gelatin; Hypromellose 2910 (3 mpa.s); Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Shellac; Sodium starch glycolate type a potato
Bristol-Myers Squibb Company	F05856	Diethyl phthalate; Sodium hydroxide; Talc; Titanium dioxide; Carboxymethylcellulose sodium; Gelatin; Methacrylic acid - methyl methacrylate copolymer (1:2); Sodium starch glycolate type a potato
------------------------------------------------------------------------------------

Didanosine 100 mg tablet

Company	Formulation ID	FDA Description
Aurobindo Pharma	F05853	Calcium carbonate; Aspartame; Magnesium stearate; Sorbitol; Magnesium hydroxide; Crospovidone; Cellulose, microcrystalline; Orange
------------------------------------------------------------------------------------

Didanosine 150 mg tablet

Company	Formulation ID	FDA Description
Aurobindo Pharma	F05854	Calcium carbonate; Aspartame; Magnesium stearate; Sorbitol; Magnesium hydroxide; Crospovidone; Cellulose, microcrystalline; Orange
------------------------------------------------------------------------------------

Didanosine 200 mg tablet

Company	Formulation ID	FDA Description
Aurobindo Pharma	F05855	Calcium carbonate; Aspartame; Magnesium stearate; Sorbitol; Magnesium hydroxide; Crospovidone; Cellulose, microcrystalline; Orange
------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4833).